UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock
International Markets and Jazz (JAZZ): A Deep Dive for Investors
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
Jazz Pharmaceuticals Q1 Review: The Oncology Pivot Is Real, And The Market Is Still Mispricing It
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations
Jazz Pharmaceuticals plc (JAZZ) Q1 2026 Earnings Call Transcript
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top Estimates
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)
Assetmark Inc. Buys 5,499 Shares of Jazz Pharmaceuticals PLC $JAZZ
Choreo LLC Acquires Shares of 2,883 Jazz Pharmaceuticals PLC $JAZZ
KBC Group NV Boosts Position in Jazz Pharmaceuticals PLC $JAZZ
Jazz Pharmaceuticals Touts Record $4.3B 2025 Revenue, Reaffirms 2026 Outlook at Conference
Jazz Pharmaceuticals plc (JAZZ) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
2,979 Shares in Jazz Pharmaceuticals PLC $JAZZ Acquired by Aaron Wealth Advisors LLC
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting
Capricorn Fund Managers Ltd Purchases New Shares in Jazz Pharmaceuticals PLC $JAZZ
Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock
Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Jazz Pharmaceuticals (JAZZ) Price Forecast: Multi-Year Base Signals Breakout Potential
Jazz Pharmaceuticals plc (JAZZ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Crossmark Global Holdings Inc. Sells 10,433 Shares of Jazz Pharmaceuticals PLC $JAZZ
JAZZ or ACAD: Which Is the Better Value Stock Right Now?
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock?
Here Are Friday’s Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More
Jazz Pharmaceuticals: Relief Rally On 2026 Oxybate Franchise's Outlook
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call Transcript
Jazz (JAZZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
What Analyst Projections for Key Metrics Reveal About Jazz (JAZZ) Q4 Earnings
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Is the Options Market Predicting a Spike in Jazz Pharmaceuticals Stock?
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026